What is APMD's current stock price?

APMD (Apnimed, Inc.) is currently trading at $16.86 with a market cap of $701.9M.

What sector is Apnimed, Inc. in?

Apnimed, Inc. (APMD) operates in the Healthcare sector, specifically in the Biotechnology industry.

InvestLog

Back to Market返回行情

APMD Apnimed, Inc.

NASDAQHealthcare

$16.86-2.77%OpenMarket Cap: $701.9M

As of 2026-10-30 10:20

Why APMD matters now

Apnimed, Inc. (APMD) is a US stock in Healthcare. The latest InvestLog snapshot shows $16.86 with -2.77% on the session and $701.9M in market capitalization.

The latest indexable market news headline is "Apnimed to Present Five Abstracts, Including Two Late-Breakers at CHEST 2026" from GlobeNewsWire.

Latest News

Apnimed to Present Five Abstracts, Including Two Late-Breakers at CHEST 2026GlobeNewsWire · 2026-10-12

Apnimed, Inc. Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)GlobeNewsWire · 2026-10-02

Apnimed, Inc. (NASDAQ:APMD) Stock Short Interest Jumps 55.7%Defense World · 2026-10-01

Apnimed, Inc. (NASDAQ:APMD) Given Consensus Rating of “Moderate Buy” by BrokeragesDefense World · 2026-09-22

Apnimed: What We Know Heading Into The Feb PDUFASeeking Alpha · 2026-09-10

Company Info

Sector

Healthcare

Industry

Biotechnology

Country

Exchange

NASDAQ

Beta

0.00

Apnimed, Inc. operates as a clinical pharmaceutical company that develops and manufactures novel oral therapies that address the neurobiology of sleep-related breathing diseases in global markets. Its products include AD109, an oral therapy designed to treat obstructive sleep apnea (OSA) by targeting the underlying neuromuscular dysfunction. The company was incorporated in 2017 and is based in Cambridge, Massachusetts.